Skip to content

Clinical trials

Phase 1 Leukemia, Myeloid, Acute trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myeloid, Acute Phase: Phase 1 Country / region: Canada Clear all

56 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20073
20092
20101
20114
20123
20131
20143
20154
20167
20175
20183
20191
20204
20211
20225
20231
20242
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Terminated20
Active, not recruiting8
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto7
National Cancer Institute (NCI)6
Hoffmann-La Roche4
Amgen3
Celgene3
AbbVie2
Astellas Pharma Global Development, Inc.2
AstraZeneca2
Bristol-Myers Squibb2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myeloid, Acute56
Myelodysplastic Syndromes15
Leukemia14
Recurrence14
Precursor Cell Lymphoblastic Leukemia-Lymphoma11
Leukemia, Myelomonocytic, Chronic7
Leukemia, Lymphocytic, Chronic, B-Cell5
Myeloproliferative Disorders5
Neoplasms5
Blast Crisis4

Trials

Showing 1 to 25 of 56. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.